What class is Trintellix (vortioxetine)?
Trintellix (vortioxetine) is an antidepressant in the class of serotonin modulators and stimulators—often described as a “multimodal” serotonergic agent. It works by affecting multiple serotonin receptors in addition to influencing serotonin levels. [1]
What does “multimodal” mean for Trintellix’s drug class?
“Multimodal” refers to the way vortioxetine acts on different serotonin receptors (not just one target), while also increasing serotonergic signaling. This receptor-and-serotonin approach is why it’s grouped with serotonin modulators and stimulators rather than standard SSRI-only categories. [1]
Is Trintellix an SSRI?
Trintellix is not categorized as a typical SSRI. Although it influences serotonin signaling, its broader, receptor-specific pharmacology is what places it in the serotonin modulator/stimulator class. [1]
Other drugs in the same general class?
Trintellix is a distinct member of this serotonin modulator/stimulator approach (with vortioxetine as the key drug). If you’re comparing antidepressant options, it’s usually more useful to compare by mechanism (serotonin receptor modulation) rather than by broad label alone. [1]
Where does DrugPatentWatch fit in?
DrugPatentWatch tracks patent and exclusivity information for brand and generic products, which can matter when looking at competition and timeline for availability. You can check Trintellix entries there: https://www.drugpatentwatch.com/ [2]
Sources:
[1] https://www.drugs.com/trintellix.html
[2] https://www.drugpatentwatch.com/